Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

ZITHROMAX FOR INTRAVENOUS INJECTION

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is ZITHROMAX FOR INTRAVENOUS INJECTION discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that ZITHROMAX FOR INTRAVENOUS INJECTION 500MG has been permanently discontinued (last updated August 2, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is ZITHROMAX FOR INTRAVENOUS INJECTION not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file6 products
Affected strength500MG
Last updated2025-08-02

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

AZITHROMYCIN FOR INJECTION, USP

HOSPIRA HEALTHCARE ULC

500MG · DIN 02334976

Same strengthSame dosage formSame routeNo current shortage

Other Products

ZITHROMAX CAP 250MG

PFIZER CANADA ULC

250MG · DIN 02091291

Different strengthDifferent dosage formDifferent routeNo current shortage

ZITHROMAX 600MG

PFIZER CANADA ULC

600MG · DIN 02231143

Different strengthDifferent dosage formDifferent routeNo current shortage

PMS-AZITHROMYCIN

PHARMASCIENCE INC

250MG · DIN 02261634

Different strengthDifferent dosage formDifferent routeNo current shortage

AZITHROMYCIN

PHARMASCIENCE INC

100MG · DIN 02274388

Different strengthDifferent dosage formDifferent routeNo current shortage

SANDOZ AZITHROMYCIN

SANDOZ CANADA INCORPORATED

250MG · DIN 02265826

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

02239952

Strength

500MG

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS

Active Ingredient

AZITHROMYCIN

See all AZITHROMYCIN products →

Shortage History